Liver Diseases

Gastroenterology·MeSH: Liver Diseases

Prevalence

5.0 / 100K

4 drugs in development·3 companies·9 clinical trials

Drug Pipeline by Phase

Preclinical(1)
DrugCompany
a2342ALBIREO PHARMA, INC. (ALBO)

Compare drugs

rencofilstat (formerly CRV431) vs etavopivatrencofilstat (formerly CRV431) vs nnc0560-0004rencofilstat (formerly CRV431) vs a2342

Frequently asked questions

How many drugs are in development for Liver Diseases?

BioSniper tracks 4 drugs in development for Liver Diseases across 3 companies.

How many clinical trials target Liver Diseases?

There are 9 clinical trials targeting Liver Diseases tracked by BioSniper.

What is the prevalence of Liver Diseases?

The estimated prevalence of Liver Diseases is approximately 5.0 per 100,000 population.

Deep-dive into Liver Diseases

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis